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Abstract. Cartilage defect has become serious problem for orthopaedic surgeon and patients 
because of its difficult healing that might occur when articular cartilage damage never reach 
subchondral layer. In this study, we used combination of freeze dried bovine cartilage (FDBC) 
scaffold, bone marrow mesenchymal stem cells (BM-MSCs), and platelet rich plasma (PRP) 
composite (SMPC) implanted in full thickness cartilage defect. This study is to explain its 
regeneration mechanism. This is true experimental research with post-test only control group design 
using New Zealand White Rabbit. 50 rabbits is divided into three groups of SMPC, BM-MSCs and 
FDBC. 37 rabbits evaluated after twelve weeks. Histopathologic examination showed the number of 
chondrocytes, collagen thickness and cartilage width are highest on SMPC group. 
Immunohistochemical examination showed SMPC group has the highest number of 
chondroprogenitor cells express FGF-2R, Sox-9, and MAPK. Brown Forsythe test resulted in 
significant increase the number of chondrocytes (p=0,010), collagen thickness (p=0,000), and 
cartilage surface width (p=0,015), and increase FGF-2R (p=0,000), MAPK (p=0,000), and Sox-9 
(p=0,000) on SMPC group. Using path analysis, there is strong influence from FGF-2R, MAPK, 
and Sox-9 to the increase of chondrocytes, collagen thickness, and cartilage surface width. Hence, 
SMPC implantation mechanism of full thickness cartilage defect regeneration can be explained. 
Introduction 
Cartilage defect is common disease found 65% cases and more than 31,000 arthroscopic 
procedures performed [1]. Articular cartilage defect has become serious problem for orthopaedic 
surgeon and patients because of its difficult healing that might occur when articular cartilage 
damage never reach subchondral layer [2]. Articular cartilage has poor regeneration ability due to 
its avascular nature, minimal cell availability, without basal membrane and nerve innervation, 
therefore it depend solely on diffusion process to gain nutrition. Full thickness cartilage defect will 
form clot surround them due to its blood supply [3]. Several measures have been developed to solve 
this problem, includes drug prescription and some operative techniques but none of these give good 
results [4]. 
Autologous Chondrocytes Implantation (ACI) is implantation procedure on full thickness 
cartilage defect isolated and cultured in monolayer and covered by sewn periosteum. Cartilage as 
chondrocytes source taken from non-weight bearing joints. But it is also bring up tissue 
hypertrophy, layer damage, graft integration failure, and chondromalacia as consequences [5,6]. 
Matrix Induced Chondrocyte Implantation (MACI) is continous improvement from ACI, an applied 
tissue engineering that combine mesenchymal stem cells or chondrocytes, and scaffold with or 
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without growth factor [7]. ACI and mosaicplasty recommended to regenerate defect in patients with 
cartilage defect diameter less than 2 cm2. Cartilage defect that is larger or replacement in almost the 
entire joint surface requires another treatment method [8]. 
Tissue engineering uses combination (chondrocytes or mesenchymal stem cells), scaffold 
and growth factors. Chondrocyte has limits include already differentiated and slow to proliferate 
after implanted, risk of contamination during isolation, and extraction more difficult in human [9]. 
Mesenchymal stem cells (MSCs) implantation will bring new hope in treatment of articular 
cartilage damage since their ability to differentiate as chondrocyte shall produce extra cellular 
matrix to regenerate cartilage defect [5]. In this study we used allogenic BM-MSCs which known 
has immunosuppressive effect and no Graft Versus Host Disease (GVHD) [10,11]. BM-MSCs in 
combination with scaffold will regenerate full thickness cartilage defect by facilitate proliferation 
and produce matrix as progenitor cells source that is more accessible, easily manipulated, and renew 
themselves [12]. 
Freeze Dried Bovine Cartilage Powder (FDBC) contains extracellular matrix and able to 
stimulate chondrogenesis such as CDMP1/GDF5 [13]. MSC-scaffold combination mixed with 
platelet rich plasma contains various growth factors. This composite will be implanted on rabbit’s 
full thickness cartilage defect with diameter 4 mm2 that is equivalent to 6 cm2 lesions on adult 
humans. But regeneration mechanism of full thickness cartilage defect using SMPC is still unclear 
according to Ornitz (2005) and Hoffmann (2004) research [14,15]. 
The aim of this study is to explain regeneration mechanism on full thickness cartilage defect 
implanted with Freeze Dried Bovine Cartilage Powder Scaffold– Mesenchymal Stem Cells–Platelet 
Rich Plasma Composite (SMPC). For further SMPC can produced so that it can begin clinical 
studies in patients with full thickness cartilage defect (clinical research). 
Materials and Methods 
This study was true experimental research with post-test only control group design using 
New Zealand white rabbit as subject. Rabbits were divided into three groups (FDBC, MSC, SMPC) 
and evaluated after twelve weeks. Microscopic and histopatologic condition were evaluated using 
histopathology and immunohistochemistry. 
SMPC Fabrication and Characterization 
 Freeze dried bovine cartilage scaffold was made through 3 stages: tissues freezing, primary 
drying using sublimation and secondary drying to remove remains of water. This product contains 
water less than 5% and its process in accordance with Tissue Bank International. 
 Rabbit’s BM-MSCs were cultured and characterized with immunohistochemical using 
monoclonal antibody FITC anti-human CD45 and FITC anti-human CD105 (Biolegend). 
Observation of CD45/CD105 performed using flourescence microscope. MSCs will show positive 
expression on CD105 in green luminescence. 
 Platelet rich plasma from rabbit’s blood was produced using centrifugation in 3000 rpm for 
15 minutes at 4°C twice. PRP-Gel active after mixed with CaCl2 and thrombin. Implantation of 
BM-MSCs was performed by mixing FDBC 20 µg and PRP 80% volume, and immersed into 
CCM's solution and stem cells suspension for 16 hours. MSCs attachment on FDBC–PRP was 
observed using Scanning Electron Microscope. 
Toxicity Tests 
 MTT assay used to determine biomaterials toxicity (in this study is FDBC) on stem cell. 
MTT assay result was analyzed using one way ANOVA statistics between MSC, MSC+PRP, 
MSC+FDBC, and MSC+FDBC+PRP groups. 
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Alloreactivity Tests 
 This test performed by implanting BM-MSCs on rabbit muscle. After 3 weeks post-
injection, samples were measured through histopathology using hematoxyllin-eosin coloring (HE). 
The number of lymphocytes, monocytes, and PMN per field of view at 10 field of view was then 
examined. 
Biocompatibility Tests 
 Biocompatibility performed through in-vivo in New Zealand White Rabbit. 50 rabbits is 
divided into three groups of SMPC, BM-MSC, and FDBC, and 37 rabbits were evaluated after  
12 weeks. Histopathology was performed by calculating macrophages in muscles, while 
immunohistochemistry identified by IL-1, which is the most significant cytokine found. 
Results 
Bone marrow mesenchymal stem cells was cultured for 2 weeks to get enough cells  
(2x106 cells). The number of MSCs which is optimal for immobilization to the defect 4 mm2 is 
1x106 per cm2. MSCs attachment on FDBC scaffold and PRP-Gel was observed as shown in  
Figure 1. 
 
Figure 1. Seeding MSCs into FDBC-PRP using SEM magnification 2000x. Black arrow is stem cell 
and blue arrow is FDBC scaffold. 
Toxicity Tests Results 
 Toxicity comparison of each material is presented in Figure 2. From one way ANOVA 
found no significant difference between MSC, MSC+PRP, MSC+FDBC, and MSC+FDBC+PRP 
(p=0,130). This means that FDBC is not toxic to stem cell. 
 
Figure 2. Toxicity test results. 
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Alloreactivity Test Results 
Alloreactivity analysis performed by measuring serum levels IL-10 and the number of 
lymphocytes, monocytes, and polimorphonuclear (PMN). Mann-Whitney analysis result showed no 
significant differences in serum levels IL-10 (p=0,250), the number of lymphocytes (p=0,130), 
monocytes (p=0,230), and PMN (p=0,340). Figure 3 (A and B) showed distribution of 
inflammatory cells did not differ significantly between treatment group and control group. 
 
Figure 3. Histopathology of femoral muscle using HE coloring, magnification 200x. Yellow arrows 
showed distribution of inflammatory cells; A. Treatment group B. Control group. 
Biocompatibility Test Results 
Macroscopic Appearance 
There is still clearly visible defect in FDBC and MSC groups. Defect in MSC almost gone even not 
covered all. SMPC group showed a good healing as shown in Figure 4. 
 
Figure 4. Macroscopic appearance in cartilage defect after 3 months. A. Implantation using FDBC; 
B. Implantation using MSC; C. Implantation using SMPC. 
Histopathology Examination 
Histopathologic examination of the number of chondrocytes and collagen thickness in each 
group shown in Figure 5 and Figure 6 (Supplementary Information). The highest results for the 
number of chondrocytes, collagen thickness, and cartilage surface width found in SMPC group. 
Brown-Forsythe Statistic analysis obtained p=0,010 (Table 1), p=0,000 (Table 2), and p=0,015 
(Table 3) which means that there are difference results between FDBC, MSC, and SMPC groups. 
Immunohistochemistry Examination 
Immunohistochemical examination of FGF-2R, MAPK, and Sox-9 shown in Figure 7, 
Figure 8, and Figure 9 (Supplementary Information). The number of condroprogenitor cells that 
express FGF2-R, MAPK, and Sox-9 most found in SMPC group. Brown-Forsythe Statistic analysis 
obtained p=0,000 in Table 4, Table 5, and Table 6 which means there are significant difference 
results between FDBC, MSC, and SMPC groups. 
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Table 1. The number of chondrocytes in three groups. 
Group n The number of chondrocytes (cells) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 41054,00a 43763,49 8217 169670 Stat=6,523 
p=0,010* MSC 12 127458,58b 101519,57 32858 340638 
SMPC 13 399885,54b 443180,89 16092 1470701 
Table 2. Collagen thickness in three groups. 
Group n Collagen thickness (µm) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 0,71a 0,19 0,31 0,97 Stat=39,833 
p=0,000* MSC 12 1,79b 0,51 0,94 2,89 
SMPC 13 2,21b 0.52 1,25 2,83 
Table 3. Cartilage surface width in three groups. 
Group n Cartilage surface width (µm2) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 30230,34a 22045,88 5556,05 79463,91 Stat=5,850 
p=0,015* MSC 12 147821,44b 118319,76 38207,64 396091,58 
SMPC 13 399973,15b 470783,74 18714,35 1710118,80 
Table 4. FGF-2R percentage in three groups. 
Group n FGF-2R (%) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 2,58a 1,73 0,94 6,34 Stat=72,106 
p=0,000* MSC 12 11,09b 11,34 1,00 34,57 
SMPC 13 42,40b 10,01 29,74 70,82 
Table 5. MAPK percentage in three groups. 
Group n MAPK (%) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 2,19a 1,64 0,88 5,35 Stat=25,651 
p=0,000* MSC 12 3,60b 2,47 0,52 8,00 
SMPC 13 9,87b 4,03 3,69 16,03 
Table 6. Sox-9 percentage in three groups. 
Group n Sox-9 (%) Brown-Forsythe 
Statistic Average SD Min Max 
FDBC 12 3,86a 2,11 1,23 7,84 Stat=29,924 
p=0,000* MSC 12 5,76b 4,55 1,43 17,01 
SMPC 13 22,10b 10,23 9,15 46,04 
Description : * significant at α=0,05 
 a,b different superscript shows the differences among groups (based on multiple 
comparisons Games-Howell) 
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Path Analysis of SMPC Effect 
 
Figure 10. Path analysis of SMPC effect in regeneration of full thickness cartliage defect. 
Path analysis (Figure 10) showed FGF-2R has  strong influence on MAPK, MAPK on Sox-
9, Sox-9 on chondrocytes, chondrocytes on cartilage, and Sox-9 on FGF-2R. 
Discussion 
SMPC composite is able to fill defect in cartilage because it is gel so it can follow the shape 
of joint surface. This study found that concentration of PRP 80% volume and scaffold 20 µg is ideal 
for MSCs growth. This is correlate with cartilage composition consists 80-90% water and 5-10% 
extracellular matrix [16]. 
Regeneration Mechanism of Full Thickness Cartilage Defect 
Brown-Forsythe Statictics analysis obtained percentage of condroprogenitor cells that 
express FGFR-2, MAPK, and Sox9, the number of chondrocytes, and collagen thickness were 
significantly higher in SMPC than in MSC and FDBC groups. This may explain regeneration 
mechanism of full thickness cartilage defect with SMPC. This mechanism involves the role of 
MSCs, FDBC, and PRP. FDBC contains chondrogenesis (CDMP1/GDF5), a BMP-like molecules 
that can bind BMP-2-1A receptor and release growth factors during injury include TGF-β, IGF, 
BMP-2, BMP-7. PRP as result of blood processing has wide variety of growth factors. In another 
study showed an increased of BMP-2 on PRP-Gel application in animal experimental [17]. This 
indicates that PRP has an important role for BMP-2 which is one of main originators of 
chondrogenesis. 
The first mechanism is BM-MSCs in SMPC which implanted in cartilage joint defect will 
bind bone morphogenetic protein-2 (BMP-2) derived from PRP, and BMP-2 binds CDMP-1 
derived from scaffold through BMPR-1A receptor which contained BM-MSCs surface. This bond 
will induce an increase in expression of fibroblast growth factor-2R (FGF-2R) and fibroblast 
growth factor-3R (FGF-3R). If there is binding between FGF-3 and FGF-3R in BM-MSCs surface, 
MSCs cytosol will be increased the activity of mitogen-activated protein kinase (MAPK). 
Furthermore, MAPK which already activated induces T-box factor (brachyury) to conduct 
upregulation expression of FGF-2R and FGF-3R and stimulates Sox-9 as chondrogenic 
transcription factor (CTF). CTF translocated into MSCs nucleus to induce mitotic genes so that they 
develop into condroprogenitor cells become chondrocytes which produce extracellular matrix. 
The second mechanism is FDBC scaffold contains CDMP-1/GDP-5 (growth factor that has 
chondrogenesis ability) will provide signaling to BM-MSCs to differentiate into condroprogenitor 
cells which subsequently became chondrocytes, as it also stimulate chondrocytes to produce 
extracellular matrix like proteoglycan and collagen, so the end result is cartilage formation. 
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The third mechanism is full thickness cartilage defect will release cytokines which is 
important in healing process include TGF-β2, IGF, BMP-2, BMP-7. Transforming Growth Factor 
beta (TGF-β) binds to TGF-βR in BM-MSCs surface along with TGF-β derived from PRP to induce 
MAPK as in first mechanism. Moreover, TGF-β, IGF-1, BMP-2, BMP-7 also role in regeneration 
of full thickness cartilage defect by stimulating chondrocytes to synthesize extracellular matrix, 
which produce cartilage formation. From all mechanisms and immuno-histochemistry, it can be 
concluded that SMPC has strong influence on growth factors. 
Regeneration Analysis Results 
Cartilage surface width in SMPC is bigger than FDBC and MSC group. The same thing 
with previous explanation that BMP-2 and BMPR-1A is important to start regeneration process of 
cartilage defect, so that in SMPC group, growth factors derived from scaffold, PRP, and defect 
cartilage will contribute more than two other groups. Another role is derived from the number of 
BM-MSCs that is more than FDBC group. Cartilage formation will also be more widely established 
in SMPC group, because BM-MSCs already proliferated and differentiated into condroprogenitor 
cells become chondrocytes and will be stimulated to produce extracellular matrix either from 
scaffold (CDMP1/GDF5) or defect (BMP-2, IGF-1, BMP-7, TGF-β). Chondrocytes which formed 
along with extracellular matrix will form cartilage wider than two other groups. 
In path analysis found the number of collagen formed is not significantly correlated with 
cartilage formation. It can be explained that evaluation of this study was conducted at 12 weeks so 
regeneration of cartilage is not perfect though chondrocytes layers has been arranged, and tidemark 
as boundary between cartilage and subchondral bone evident at week-24, and not all 
condroprogenitor differentiated into chondrocytes to produce collagen [18]. 
Comparison of SMPC Results to Other Methods 
Cartilage from SMPC group showed a good incorporation in microscopic. Scaffold as an 
important medium will regenerate cartilage if accompanied by optimum administration of MSCs. 
This proves that the defect which is given only by scaffold does not get adequate number of MSCs 
to repair. The same thing with MSCs only that is not good enough to repair because cells would be 
out of defect area due to gravity as in the ACI. This study obtained regeneration results better than 
Junji which is using the ACI technique, where obtained uneven cells at the sites of implantation 
[19]. 
This study obtained surface cartilage regeneration same level with normal cartilage surface 
on 12 weeks evaluation post-implantation. This result is better than Niswander study in rats, which 
is implanted BM-MSCs on full thickness cartilage defect without using scaffold in treatment group, 
and comparison group made defects of the same size at 2 mm x 2,5 mm x 1 mm which is given by 
FBS only. The results obtained cartilage regeneration was better but still there are hollows on the 
surface or is not level with normal cartilage [20]. 
Wakitani conducted a study regeneration on full thickness cartilage defect in New Zealand 
white rabbit by making a hole size of 6 x 3 x 3 mm. In defect given treatment using implantation of 
BM-MSCs + collagen gel, compared to treatment of BM-MSCs and defect only. The results 
obtained in BM-MSCs + collagen gel and BM-MSCs did not differ significantly, but it's better than 
just by defect only. On 12 weeks evaluation, in BM-MSCs + collagen gel group and BM-MSCs 
group obtained regeneration of cartilage surface is thinner and the surfac is irregular (not flat). In 
this study, SMPC on 12 weeks evaluation showed better results in cartilage regeneration, which is 
thickness and flat (regular) [21]. 
The new findings in this study are: first, FDBC is still contains organic cartilage compared 
to hyaluronan or collagen which is currently most popular and widely used. FDBC has never been 
used as scaffold for cartilage regeneration. Second, SMPC both in in-vitro and in-vivo is an ideal 
composition for tissue engineering on full thickness cartilage defect. 
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Conclusion 
Regeneration mechanism of full thickness cartilage defect in SMPC is through MSC FGF-2R 
signals in surface which is attached to scaffold and will be forwarded to MAPK in nucleus, thus 
synthesize Sox-9. Protein Sox induces MSC proliferation and maturation into chondrocytes. 
Chondrocytes synthesize collagen type 2 but in regulated number so that regeneration of cartilage in 
accordance with joint cartilage. 
Abbreviations 
FDBC  : Freeze Dried Bovine Cartilage 
BM-MSCs : Bone Marrow Mesenchymal Stem Cells 
MSC  : Mesenchymal Stem Cell 
PRP  : Platelet Rich Plasma 
SMPC  : FDBC Scaffold – MSC – PRP Composite 
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Figure 5. The number of chondrocytes in joint defect. Blue arrows show the growth of joint 
cartilage (condrogenesis). A: implanted with FDBC scaffold (preparation no.2, HE, x100). B: HE, 
x400, R: cavities; K: chondrocytes. C: implanted with MSC (preparation no.12, HE, x100) seem 
less horizontal surface. D: HE, x400. E: implanted with SMPC (preparation no.12, HE, x100) 
cartilage growth appears flat. F: shows the growth of joint cartilage homogeneous; K: condroblast 
(HE, x400). 
Journal of Biomimetics, Biomaterials and Biomedical Engineering Vol. 31 77
 
Figure 6. Collagen thickness in joint defect. Blue arrows show the growth of joint cartilage 
(condrogenesis). Preparation using collagen type-2 mAb, which showed positive reaction in brown 
color. KL: indicates collagen thickness. A. implanted with FDBC scaffold (preparation no.6, CPI, 
x100) B: CPI, x400. C: implanted with MSC (preparation no.3, CPI, x100). D: CPI, x400. E: 
implanted with SMPC (preparation no.2, CPI, x100). F: CPI, x400. 
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Figure 7. The number of condroprogenitor cells expressed FGF2-R in joint defect. Blue arrows 
show the growth of joint cartilage (condrogenesis). Preparation using mAb FGF-2R, which showed 
positive reaction in brown color, not brown means negative. A. implanted with FDBC scaffold 
(preparation no.6, CPI, x100) B: CPI, x400. C: implanted with MSC (preparation no.5, CPI, x100). 
D: CPI, x400. E: implanted with SMPC (preparation no.12, CPI, x100). F: CPI, x400. 
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Figure 8. The number of condroprogenitor cells expressed MAPK in joint defect. Arrows show 
the growth of joint cartilage (condrogenesis). Preparation using mAb MAPK, which showed 
positive reaction in brown color, not brown means negative. A. implanted with FDBC scaffold 
(preparation no.6, CPI, x100) B: CPI, x400. C: implanted with MSC (preparation no.5, CPI, x100). 
D: CPI, x400. E: implanted with SMPC (preparation no.12, CPI, x100). F: CPI, x400. 
80 Journal of Biomimetics, Biomaterials and Biomedical Engineering Vol. 31
 
Figure 9. The number of condroprogenitor cells expressed Sox-9 in joint defect. Arrows show 
the growth of joint cartilage (condrogenesis). Preparation using mAb Sox-9, which showed positive 
reaction in brown color, not brown means negative. A. implanted with FDBC scaffold (preparation 
no.6, CPI, x100) B: CPI, x400. C: implanted with MSC (preparation no.5, CPI, x100). D: CPI, 
x400. E: implanted with SMPC (preparation no.12, CPI, x100). F: CPI, x400. 
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